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Carcinogenicity Studies on
Vinylidene Chloride
by P. L. Viola* and A. Caputo*
Results of a study on Wistar rats regarding a possible carcinogenic effect of vinylidene chloride (VDC)
were presented previously by one of the authors.
Due to the unclear character of these results, a second inhalation study was initiated with Sprague-
Dawley rats. Groups of60 animals were exposed to 100 and 75 ppm VDC, along with one control group. A
final report on the pathological results must await completion of the microscopic examination of the
tissues and organs from all the animals. Nevertheless, it seems clear that there is no grossly observable
interrelation between tumor production and VDC inhalation.
As in the case of vinyl chloride, the problem of
vinylidene chloride (VDC) is of primary impor-
tance in the field of environmental health research.
Vinylidene chloride produces no clear signs of tox-
icity apart from a reduced growth rate observed in
some animal species by Prendergast et al. (1) and
the production ofseveral types ofliverdamage after
3 months exposure (24 hr/day to 47 ppm). At VDC
concentrations of 500 ppm, Cage (2) reported that
rats exposed to 6 hr/day for 20 days had nose irrita-
tion, retarded growth rate, and histologically
proven liver cell degeneration. This lesion disap-
peared when the concentration was lowered to 200
ppm. At this lower concentration a complete au-
topsy found all organs normal, while in the living
animals only a slight nose irritation was observed.
Carpenter et al. (3) reported that the LC50 of VDC
is 32,000 ppm in Sherman rats repeatedly exposed for
4 hr/day.
No effects were seen by Norris in rats exposed
from 10 to 40 ppm VDC vapors for 30 days (4). The
only significant finding in Sprague-Dawley rats ex-
posed for 30 or 90 days to 25 or 75 ppm was a
minimal vacuolation of cytoplasm in hepatocytes.
This lesion reversed when the animals were re-
moved from VDC exposure. Subsequent interim
kills at 6 and 12 months confirmed the occurrence of
minimal liver injury.
*Regina Elena Institute for Cancer Research, Rome, Italy.
In the 1977 MCA study (5), Norris reported that
gross pathological examinations of rats exposed to
VDC in inhalation chambers showed no
compound-related changes in liver, urinary system,
respiratory system, or lymphoreticular system.
In a very preliminary account given at the Xlth
International Cancer Congress (6) one of us
(P.L.V.) discussed the possible carcinogenic role of
VDC by examining the data ofa single experiment.
In 1975 a systematic investigation of the potential
carcinogenic action of VDC was launched.
The inhalation system was similar to that re-
ported in a previous experiment (7). Inhalation was
performed with VDC purchased from Fluka, purity
99.8%, and thus was assumed to contain no sig-
nificant amounts of various carcinogenic contami-
nants. Since VDC is liquid at room temperature, it
was necessary to heat it to its boiling point
(31.9°C/766 mm Hg). The VDC vapor was col-
lected in a reservoir maintained at the same temper-
ature, and was mixed with a constant amount of
air at 32°C in order to reach the desired concentra-
tion. This continuously generated atmosphere, was
passed throughout the exposure chambers, accord-
ing to the experimental design reported in the case
of the vinyl chloride experiments (7)
In the first experiment, from July 1973 to July
1975, 74 male and female, 2-month-old albino Wis-
tar rats were submitted to VDC inhalation for 4
hr/day, 5 days/week for 12 months. Until the end of
the fifth month, the VDC concentration was kept at
200 ppm, from the sixth month on it was lowered to
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prolonged exposure. Experimental animals were
checked and weighed weekly; those developing
poorly were isolated in separate cages. The animals
were allowed to die spontaneously or were killed
when moribund. The total life span of the ex-
perimental rats ranged from 22 to 24 months, and
was therefore shorter than those kept as control and
maintained under the same conditions, except for
the inhalation of VDC. Complete autopsies were
performed on all experimental and control animals.
Around the tenth month of inhalation, the occur-
rence of hard masses next to the external ear ducts
was frequently observed. The rapid growing masses
became ulcerated and discharged necrotic debris.
Biopsies at different times indicated the presence of
chronic inflammatory reactions but neoplastic
transformation of dermal and/or epidermal tissues
was never observed.
The results ofthis first experiment are reported in
Table 1. Tumors are in the abdominal cavity except
for one in the liver and one in the lung. Almost all
the tumors appeared as large and compact masses
located in the middle or lower part of the abdomen
and displacing or destroying the intestines. The
prominent histological polymorphism and the poor
degree ofdifferentiation ofthese cells indicated that
the prevailing components were stem-cells, primi-
tive reticulum cells, for merely undifferentiated
mesenchymal cells. Because ofthese properties and
the occurrence of a loose meshwork of reticulin ar-
gyrophilic fibrils, the diagnosis of "reticulum cell
sarcomas of a nonsincytial type" seems the most
appropriate.
Table 1. Tumor incidence in Wistar rats inhaling VDC.
Number of Sites ofprimary tumors
Number tumor-
of bearing Abdominal % of
rats Sex animals cavity Lung Liver total
51 M 8 7 1 16
23 F 9 8 1 39
As reported in Table 2, many abdominal tumors
were also found in control rats. The higher inci-
dence of tumors in female rats was confirmed. Mi-
croscopically, the tumors were essentially similar in
both the VDC inhaling and control groups.
The second study, which is far enough along to
be reported, concerned the use of Sprague-Dawley
rat, which seemed ofinterest in view ofits different
toxicological sensitivity. This inhalation study was
started in the summer of 1975. Rats were exposed
to VDC concentrations of 100 and 75 ppm VDC,
along with one series of controls. As reported in
Table 3, the gross pathological examinations of the
dead animals and those sacrificed in moribund con-
ditions indicated that in the control group the inci-
dence of tumors was practically identical to that
found in the group inhaling 100 ppm VDC and was
higher than that observed in the group inhaling 75
ppm VDC.
Table 2. Tumor incidence in control Wistar rats.
Number of Sites of primary tumors
Number tumor
of bearing Abdominal % of
rats Sex animals cavity Lung Liver total
30 M 5 5 17
30 F 10 9 1 33
Table 3. Incidence of tumors in Sprague-Dawley rats.
Number
Num- of tumor-
ber of bearing %of
rats Sex Treatment animals Types of tumors total
30 M VDC 3 Abdominal lymphomas 10
inhalation,
100 ppm
30 F VDC 17 Subcutaneous fibromas(16) 57
inhalation, Abdominal lymphoma(l)
100 ppm
16 M VDC I Subcutaneous fibroma 6
inhalation,
75 ppm





30 F None 15 Subcutaneous fibromas 50
A final statement ofthe pathological results must
await the completion of the microscopic examina-
tions of the tissues and organs of all animals.
Nevertheless, it seems clear that there is no grossly
observable correlation between tumor formation
and VDC inhalation.
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